METLEN

METLEN reported record H1 2026 results with revenue of €3,987m (+11% YoY) and EBITDA of €550m (up from €445m). Net profit after minorities rose to €313m (from €254m) and net leverage fell to 1.7x from 3.1x after reducing adjusted net debt by €728m. The company reaffirmed 2026 EBITDA guidance of €1.00–1.15bn and its medium-term EBITDA target of ~€1.92–2.08bn, alongside progress on key legacy contracts and new offtake for 25% of gallium production, which helps de-risk expansion.

Analysis

This is primarily a balance-sheet rerating story, not just a beat. Getting leverage down that fast materially lowers equity-risk premium and should expand METLEN’s buyer base from event-driven investors to quality industrial compounders over the next 6-12 months. The market will care less about the absolute earnings print than whether management can keep capital intensity disciplined while the business looks more self-funding.

The gallium offtake is the more interesting second-order signal: it turns a niche byproduct into strategic optionality and improves financeability of the upstream expansion. If that agreement is with a hyperscaler or semiconductor OEM, it also validates willingness to pay for non-China supply, which is supportive for European critical-minerals projects but likely a multi-quarter, not immediate, earnings driver. The bigger implication is that METLEN is positioning itself as a vertically integrated “scarcity premium” supplier rather than a commodity cyclical.

The main risk is execution fatigue in the legacy contract cleanup. If those projects continue to require incremental completion costs, the market will keep discounting headline EBITDA and treat storage growth as capital-consuming rather than value-accretive. Near term, the stock should react to the cash-flow and deleveraging surprise; over 1-3 quarters, the key falsifier is any sign that leverage snaps back above ~2x or that the medium-term EBITDA bridge requires further add-backs.

Key Decisions for Investors

• Long LSEGY on post-print weakness for a 3-6 month rerating trade; thesis is de-risked leverage and optionality, with downside if net leverage reverts above 2.0x on the next update.
• If already long LSEGY, hold through the next two quarters and use any gap-up to reduce only if management does not quantify upside from storage/gallium by the next earnings call.
• Initiate a call-spread structure in LSEGY for a 3-6 month horizon if liquidity is sufficient; this expresses the balance-sheet rerating without paying full delta for execution risk.
• Watch for confirmation of recurring storage EBITDA and no further legacy-contract provisions; if Q3/Q4 show another round of completion costs, fade the move and consider a short against European industrial/renewables proxies.
• Do not chase a thematic read-through into GOOGL; the strategic-minerals optionality is real but too small to move a mega-cap tech cash flow profile in the near term.